Recombinant humanized monoclonal antibody against CD18 (rhuMAb CD18) in traumatic hemorrhagic shock: Results of a phase II clinical trial

P. Rhee, J. Morris, R. Durham, C. Hauser, M. Cipolle, R. Wilson, F. Luchette, N. McSwain, R. Miller, P. B. Angood, M. Moncure

Research output: Contribution to journal › Article › peer-review

39 Scopus citations

Fingerprint

Dive into the research topics of 'Recombinant humanized monoclonal antibody against CD18 (rhuMAb CD18) in traumatic hemorrhagic shock: Results of a phase II clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences